MD: QIAGEN to Expand U.S. Headquarters and Manufacturing Facility
22 Jan, 2021
QIAGEN North American Holdings is expanding its United States Headquarters and research and development manufacturing facility, as well as leasing additional space in the area. QIAGEN plans to renovate its 146,000-square foot manufacturing facility in Germantown to accommodate expanded production of testing products for COVID-19 and other diseases.
As part of the expansion, the company has already added around 80 contracted staff and invested over $7 million in building renovations and equipment. QIAGEN is planning to further increase investments and to add additional jobs to its current more than 300 employees over the next five years. Headquartered in the Netherlands, QIAGEN provides sample to insight solutions that help to achieve scientific breakthroughs and improve healthcare to more than 500,000 customers around the world. The company recently added several new products to make COVID-19 testing quicker and more efficient. QIAGEN employs more than 5,300 people in over 35 locations worldwide.
“Montgomery County and Maryland continue to be wonderful to work with,” said Sean D. Augerson, vice president and head of operations Americas and Asia Pacific. “We needed assistance in moving forward quickly with clean room construction and getting equipment in, and they gave us that ability. We are delighted to continue expanding our presence here in Germantown.”
Since April, QIAGEN has provided the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine (UMSOM) with the reagent kits necessary for it to scale up its Large-Scale COVID-19 Testing Program. QIAGEN leveraged its pre-existing relationship with IGS to quickly understand and meet the needs of Maryland’s testing community. IGS and the UMSOM Department of Pathology now analyze thousands of tests daily.
“We are proud to support the important work that QIAGEN is doing right here in Maryland to help in the fight against COVID-19,” said Governor Larry Hogan. “For more than two decades, QIAGEN has been growing and adding jobs in our state, and we are excited that they are continuing to invest here and applaud their contributions to help address this global pandemic.”
(c)2003-2021 Trade & Industry Development is a publication of Due North Media - a division of Due North Consulting, Inc.
Copyright 2001-2021, Due North Consulting, Inc. -- All rights reserved.
The material on this site is protected by United States copyright and other intellectual property laws and may not be reproduced, rewritten, distributed, re-disseminated, transmitted, cached, displayed, published, broadcast, directly or indirectly, in any medium without the prior written permission of Due North Consulting, Inc.